Today: February 21, 2018, 6:23 pm

Creative Bioarray Launches Diseased Primary Cells to the Global Scientific Community

Creative Bioarray has launched a larger range of diseased primary cells to academic, pharmaceutical, and biotechnology organizations.
Creative Bioarray
Creative Bioarray 2015-11-20 15:15:46
Creative Bioarray, a global leader in the supply of research-use cells, including primary cells, tumor cells, stem cells and transformed cells, etc, has announced today the launch of a larger range of diseased primary cells to academic, pharmaceutical, and biotechnology organizations committed to biological research.

Creative Bioarray has gradually established a nationwide network of clinical collection sites to supply various types of disease cells for research use. The newly released cells include a series of products, such as Bone Marrow Mononuclear Cells( ..), Bone Marrow Stromal Cells (Diabetes Type I: ..), Peripheral Blood Mononuclear Cells(CML: ..), etc. These cells can be used to investigate the immune system, stem cells, and regenerative medicine.

"Actually, Creative Bioarray is always contributing to scientific breakthroughs and discoveries through the provision of high quality biological products and services to research community. These series of diseased primary cells are good examples. We're also honored to partner with global researchers to accelerate breakthroughs in disease research," stated Dennis A. Walker, Ph.D., the senior scientific officer at Creative Bioarray.

"As the biological resource center that global researchers have relied on for over a decade, Creative Bioarray is pleased to provide diseased primary cells to customers for better understanding of diseases and further drug development toward new therapies for patients. And these cells are definitely important tools for such efforts." said Dr. Hannah Cole, the senior scientific officer of R&D department of Creative Bioarray.

For more detailed information on the newly released diseased primary cells( ..), please contact Creative Bioarray by calling 1-631-626-9181 or via e-mail at

About Creative Bioarray:

Found in 2004, Creative Bioarray is an innovative biotechnology company whose mission is to develop unique technologies that provide researchers with the tools to investigate life science.

Creative Bioarray provides a wide range of high quality normal human and animal cells, cell culture medium and reagents, FISH probes, tissue array, microorganisms, equipments and related services for the research community. Their products are currently used around the world in the biological laboratories of universities, government institutes, biotechnology and pharmaceutical companies in more than 50 countries and districts.


Phone: 1-631-626-9181

Fax: 1-631-614-7828

Address: 45-1 Ramsey Road, Shirley, NY 11967, USA


Press Information
Creative Bioarray
45-1 Ramsey Road, Shirley, NY 11967, USA

Steven Rios

# 418 Words
Related Articles
More From Miscellaneous
Zero Partner Disturbance – Try a Kip [..]
Forty Winks and SleepMaker have teamed up to make their very own mattress in a box called Kip Set. The [..]
Bring Adoration to Those You Care About [..]
The fantastic feeling of adoration you leave on your relatives when you send them an exquisite bouquet of flowers can [..]
Black Friday Deals on Organic and All-Natural [..]
Chewing & Barking Offers Storewide Discount with $10 Gift Card Giveaway! November 13, 2017 – Chewing & Barking, an online [..]
Way2flowers Flower Delivery Services Online In Gurgaon [..]
This online shop is recommended by almost every customer who has bought and sent flowers to Gurgaon online [ Many [..]
Valgorect Gel For Hallux Valgus Treatment Is [..]
Valgorect LLC (a beauty-oriented company, situated in the USA), manufactured a new product, intended to treat the so common condition [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.